About Us | Contact

Dr. Jaron Thaddeus Abbott

NPI1053565978
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$30,313.57
from 52 payments in the last 6 years

Total Cash or Cash Equivalent

$30,255.27
from 49 payments in the last 6 years

Total In-kind Items & Services

$58.30
from 3 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
11/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $349.26 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575389
11/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $294.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575387
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $14.68 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575385
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $379.66 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575383
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $282.80 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575381
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $47.57 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575379
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $50.99 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575377
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $313.20 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575375
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $149.45 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575373
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $337.59 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575371
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $39.11 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575369
12/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575367
11/13/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575365
11/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $500.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575363
11/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575361
10/23/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575359
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $300.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575357
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575355
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575353
07/10/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575351
02/27/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 812575349
11/23/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 753929828
12/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $1550.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 753929826
12/07/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $114.46 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 753929824
11/09/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 753929822
02/22/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $15.63 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 725479617
02/22/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $95.96 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 725478999
02/22/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 725478991
02/22/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 725478983
08/25/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $158.67 Details
Payment from NOVARTIS PHARMACEUTICALS CORPORATION
Payment Record ID 709072725
04/14/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $107.37 Details
Payment from NOVARTIS PHARMACEUTICALS CORPORATION
Payment Record ID 709072723
02/28/2019 General (Non-Research) In-kind items and services Food and Beverage $23.52 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 685516881
02/23/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 658970793
09/08/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689049
08/25/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $314.90 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689043
08/25/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689039
08/25/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $270.32 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689031
08/04/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689025
03/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1350.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689019
04/14/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1100.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689015
03/17/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $419.65 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689007
10/22/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1150.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607689001
03/11/2017 General (Non-Research) In-kind items and services Travel and Lodging $18.73 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619305
02/04/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1000.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619301
03/11/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619297
03/04/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619291
02/25/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619287
02/11/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619281
01/21/2017 General (Non-Research) Cash or cash equivalent Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619275
10/28/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619269
10/28/2017 General (Non-Research) In-kind items and services Travel and Lodging $16.05 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619263
10/21/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 503619255
;